Abstract
Zika virus (ZIKV) infection is an aggravating factor of public health, with high morbidity associated with congenital infection and, to date, there is no vaccine licensed for use. ZIKV infections in pregnant women and cases of congenital ZIKV syndrome remain active, which highlights the need to develop prophylactic vaccine strategies to face this scenario. In this project, we will work wi…